Home
BHC
BHC News

Latest Bausch Health Companies Inc. (BHC) News on February 22, 2025

3 US Growth Companies With Up To 28% Insider Ownership

Simply Wall St.

a day ago

3 US Growth Companies With Up To 28% Insider Ownership

Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?

Insider Monkey

2 days ago

Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?

Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales

Zacks

2 days ago

Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales

MT Newswires

2 days ago

RBC Capital Adjusts Bausch + Lomb Price Target to $22 From $18, Maintains Outperform Rating

Thomson Reuters StreetEvents

2 days ago

Q4 2024 Bausch + Lomb Corp Earnings Call

Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics

Zacks

3 days ago

Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics

Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates

Zacks

3 days ago

Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates

Associated Press Finance

3 days ago

Bausch: Q4 Earnings Snapshot

MT Newswires

3 days ago

Bausch Health Swings to Q4 Profit, Revenue Increases -- Shares Rise After Hours

MT Newswires

3 days ago

Bausch Health Up 2.8% After Hours as Its Q4 Adjusted Profit, Revenue, Advance

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

ACCESS Newswire

3 days ago

Bausch Health Announces Fourth Quarter and Full-Year 2024 Results

MT Newswires

3 days ago

Sector Update: Health Care Stocks Steady Premarket Wednesday

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Yahoo Finance

3 days ago

Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent

Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates

Zacks

3 days ago

Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates

Bausch & Lomb to shake up contact lenses with deal off the table

Yahoo Finance Video

3 days ago

Bausch & Lomb to shake up contact lenses with deal off the table

MT Newswires

3 days ago

Bausch + Lomb Higher in U.S. Pre-market After Posting Increase in Q4 Adjusted Profit, Revenue

MT Newswires

3 days ago

Bausch + Lomb Q4 Adjusted Earnings, Revenue Rise; 2025 Sales Guidance Set

Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue

StockStory

3 days ago

Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue

Associated Press Finance

3 days ago

Bausch + Lomb: Q4 Earnings Snapshot

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

StockStory

4 days ago

Bausch + Lomb (BLCO) Reports Earnings Tomorrow: What To Expect

What Analyst Projections for Key Metrics Reveal About Bausch (BHC) Q4 Earnings

Zacks

5 days ago

What Analyst Projections for Key Metrics Reveal About Bausch (BHC) Q4 Earnings

Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key Metrics

Zacks

5 days ago

Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key Metrics

Bausch Health Companies Inc. (NYSE:BHC) Could Be Less Than A Year Away From Profitability

Simply Wall St.

6 days ago

Bausch Health Companies Inc. (NYSE:BHC) Could Be Less Than A Year Away From Profitability

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

ACCESS Newswire

8 days ago

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Earnings Preview: Bausch Health (BHC) Q4 Earnings Expected to Decline

Zacks

10 days ago

Earnings Preview: Bausch Health (BHC) Q4 Earnings Expected to Decline

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

ACCESS Newswire

12 days ago

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty

BioPharma Dive

15 days ago

Bain buys Mitsubishi pharma unit; Bausch + Lomb deal talks come up empty

MT Newswires

16 days ago

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires

16 days ago

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires

16 days ago

Sector Update: Health Care

Bausch + Lomb Sale Stumble Frustrates Bausch Health Investors

Bloomberg

16 days ago

Bausch + Lomb Sale Stumble Frustrates Bausch Health Investors

MT Newswires

16 days ago

Bausch + Lomb Says it Won't Go Private at This Time; Shares Fall

MT Newswires

16 days ago

Bausch + Lomb Down 7% In US Premarket As Potential Sale Plans Shelved

Contact lens maker Bausch + Lomb rules out take-private deal

Reuters

16 days ago

Contact lens maker Bausch + Lomb rules out take-private deal

Bausch Health Provides Update on Strategic Alternatives

ACCESS Newswire

16 days ago

Bausch Health Provides Update on Strategic Alternatives

MT Newswires

23 days ago

RBC Previews Bausch Health Q4

MT Newswires

23 days ago

Bausch Health Q4 Results to Focus on 2025 Outlook, Potential Full Separation of Bausch + Lomb, RBC Says

MT Newswires

23 days ago

RBC Lowers Price Target on Bausch Health to $10 From $11, Keeps Sector Perform Rating

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

ACCESS Newswire

a month ago

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

MT Newswires

a month ago

Market Chatter: Bausch Health Swaps Out Advisers After Years of Debt, Sale Talks

Bausch Health Swaps Out Advisers After Years of Debt, Sale Talks

Bloomberg

a month ago

Bausch Health Swaps Out Advisers After Years of Debt, Sale Talks

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

MT Newswires

a month ago

RBC on FDA's Third Tentative Approval For Rifaximin 550mg to Amneal Pharmaceuticals

MT Newswires

a month ago

Bausch Health's Xifaxan Selected for Medicare Drug Price Negotiations

MT Newswires

a month ago

Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

ACCESS Newswire

a month ago

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

Wall Street Analysts See a 25.5% Upside in Bausch (BHC): Can the Stock Really Move This High?

Zacks

a month ago

Wall Street Analysts See a 25.5% Upside in Bausch (BHC): Can the Stock Really Move This High?

Strength Seen in BridgeBio Pharma (BBIO): Can Its 16.0% Jump Turn into More Strength?

Zacks

a month ago

Strength Seen in BridgeBio Pharma (BBIO): Can Its 16.0% Jump Turn into More Strength?

MT Newswires

a month ago

Bausch + Lomb Acquires Whitecap Biosciences, Financial Details Not Disclosed

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?

Insider Monkey

a month ago

Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?

Is Bausch Health Companies (BHC) the Best Medical Stock to Buy Under $20?

Insider Monkey

a month ago

Is Bausch Health Companies (BHC) the Best Medical Stock to Buy Under $20?

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

Zacks

a month ago

Here's Why Bausch Health (BHC) is a Strong Momentum Stock

Is Bausch Health Companies (BHC) Among Billionaire Paul Singer’s Top Long-Term Stock Picks?

Insider Monkey

2 months ago

Is Bausch Health Companies (BHC) Among Billionaire Paul Singer’s Top Long-Term Stock Picks?

Contact lens maker Bausch + Lomb says it is exploring sale

Reuters

2 months ago

Contact lens maker Bausch + Lomb says it is exploring sale

MT Newswires

2 months ago

Bausch Health Says Bausch + Lomb Subsidiary Sale Under Consideration

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

ACCESSWIRE

2 months ago

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

Eye health company Bausch + Lomb’s affiliate acquires Elios Vision

Medical Device Network

2 months ago

Eye health company Bausch + Lomb’s affiliate acquires Elios Vision

MT Newswires

2 months ago

TSX Closer: The Market Surges as the Bank of Canada Makes Its Jumbo Cut, Further Cuts Predicted

MT Newswires

2 months ago

Sector Update: Health Care Stocks Retreat Wednesday Afternoon

MT Newswires

2 months ago

TSX up 105 Points at Midday, With Info Tech, Energy, Higher; Healthcare The Biggest Decliner

MT Newswires

2 months ago

Bausch + Lomb Shares Fall After Citigroup Downgrade, Blackstone's Reported Exit From Takeover Bid

Investing.com

2 months ago

Bausch + Lomb down after report that Blackstone could back away from takeover bid

MT Newswires

2 months ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Wednesday

MT Newswires

2 months ago

Bausch+Lomb Down 10% in US Premarket After Acquiring Elios Vision for Undisclosed Sum

MT Newswires

2 months ago

Market Chatter: Blackstone Withdraws From Bausch + Lomb Takeover Talks

Why Is Bausch Health Companies Inc. (BHC) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

Insider Monkey

2 months ago

Why Is Bausch Health Companies Inc. (BHC) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day

ACCESSWIRE

3 months ago

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day

MT Newswires

3 months ago

Morgan Stanley Downgrades Bausch + Lomb to Equalweight

Bausch Health Appoints New Chief Medical Officer and Head of R&D

ACCESSWIRE

3 months ago

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Why Bausch Health Companies (BHC) is One of the Best Canadian Stocks to Buy Under $10?

Insider Monkey

3 months ago

Why Bausch Health Companies (BHC) is One of the Best Canadian Stocks to Buy Under $10?

Why Is Bausch (BHC) Down 11.7% Since Last Earnings Report?

Zacks

3 months ago

Why Is Bausch (BHC) Down 11.7% Since Last Earnings Report?

Bausch Health Companies Inc. (NYSE:BHC) is favoured by institutional owners who hold 56% of the company

Simply Wall St.

3 months ago

Bausch Health Companies Inc. (NYSE:BHC) is favoured by institutional owners who hold 56% of the company

Bausch (BHC) Upgraded to Buy: Here's What You Should Know

Zacks

3 months ago

Bausch (BHC) Upgraded to Buy: Here's What You Should Know

MT Newswires

3 months ago

Bausch Health Canada Receives Reimbursement Recommendation for Acne Treatment

MT Newswires

3 months ago

Bausch Acne Gel Gets Reimbursement Nods from Canada's Drug Agency and Quebec's INESSS

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

ACCESSWIRE

3 months ago

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

ACCESSWIRE

3 months ago

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term

Zacks

4 months ago

Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term

MT Newswires

4 months ago

RBC on Bausch Health's Q3

Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales

Zacks

4 months ago

Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales

MT Newswires

4 months ago

RBC Lifts Price Target on Bausch Health to $11 From $10, Keeps Sector Perform Rating

Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

GuruFocus.com

4 months ago

Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...

Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics

Zacks

4 months ago

Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics

Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates

Zacks

4 months ago

Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates

Associated Press Finance

4 months ago

Bausch: Q3 Earnings Snapshot

MT Newswires

4 months ago

Bausch Health up 5.5% in New York Trade as It Reports a Higher Adjusted Third-Quarter Profit, Ups Guidance

Bausch Health Announces Third Quarter 2024 Results

ACCESSWIRE

4 months ago

Bausch Health Announces Third Quarter 2024 Results

Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

4 months ago

Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

MT Newswires

4 months ago

Bausch + Lomb Q3 Adjusted Earnings Fall, Revenue Climbs; 2024 Revenue Guidance Raised

Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates

Zacks

4 months ago

Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates

MT Newswires

4 months ago

Bausch + Lomb Q3 Adjusted Profit Falls, Revenue up 19%

Associated Press Finance

4 months ago

Bausch + Lomb: Q3 Earnings Snapshot

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence

ACCESSWIRE

4 months ago

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence

Bausch Health (BHC) Reports Next Week: What to Expect

Zacks

4 months ago

Bausch Health (BHC) Reports Next Week: What to Expect

MT Newswires

4 months ago

Bausch + Lomb Q3 Report Likely to Focus on Potential Sale, Dry Eye Disease Drugs, RBC Says

MT Newswires

4 months ago

RBC Previews Bausch + Lomb's Q3

MT Newswires

4 months ago

Market Chatter: Banks, Equity Firms Vying to Fund Potential Bausch + Lomb Buyout Deal

Banks, Private Credit Vie for $5 Billion Bausch + Lomb Debt

Bloomberg

4 months ago

Banks, Private Credit Vie for $5 Billion Bausch + Lomb Debt

Bausch Health call volume above normal and directionally bullish

TipRanks

4 months ago

Bausch Health call volume above normal and directionally bullish

Share on Social Networks: